DefinitionThe rate of death from all cancers per 100,000 persons.
NumeratorNumber of deaths due to cancer (ICD-10 codes C00-C97).
DenominatorPopulation of Utah or U.S. for a given time period.
Why Is This Important?Cancer is the second leading cause of death in the U.S. and in Utah. According to the Agency for Healthcare Research and Quality, the financial costs of cancer are substantial, with the overall annual direct medical costs for cancer estimated at $88.7 billion in 2011 in the U.S. Treatment for lung, prostate, and breast cancers accounts for more than half of the direct medical costs.
Cancer generally develops over several years and has many causes. Several factors both inside and outside the body contribute to the development of cancer. Some of these factors include genetics, tobacco, diet, weight, physical inactivity, and excessive sunlight exposure. Other factors include exposure to ionizing radiation and environmental chemicals that may be present in the workplace, food, air, or water such as asbestos, benzene, and arsenic.
Healthy People Objective C-1:Reduce the overall cancer death rate
U.S. Target: 161.4 deaths per 100,000 population
Other ObjectivesUtah's 42 Community Health Indicators[[br]]
CSTE Chronic Disease Indicators
How Are We Doing?The Utah age-adjusted cancer mortality rate had been steadily decreasing, from a high of 162.7 deaths per 100,000 population in 1991 to 124.1 per 100,000 population in 2009. Rates have fluctuated up and down since 2009. In 2017, the age-adjusted cancer mortality rate in Utah was to 120.3 per 100,000 population.
During the combined years of data from 2015 to 2017 significant differences in mortality rates existed between Utah Small Areas. The cancer mortality rate ranged from a high of 216.7 per 100,000 population in Magna to a low of 70.0 per 100,000 population in Nephi/Mona.
How Do We Compare With the U.S.?The age-adjusted cancer mortality rate in Utah has been consistently lower then the U.S. age-adjusted cancer mortality rate. For example, in 2017, the U.S. cancer mortality rate was 152.5 per 100,000 population compared with the Utah cancer mortality rate of 120.3 per 100,000 population.
What Is Being Done?The Utah Department of Health initiated the Utah Cancer Action Network (UCAN), a statewide partnership whose goal is to reduce the burden of cancer. The mission of the UCAN is to lower cancer incidence and mortality in Utah through collaborative efforts directed toward cancer prevention and control. As a result of this planning process, objectives and strategies have been developed by community partners regarding the early detection of cervical, lung, prostate, skin, breast, ovarian, and colorectal cancers as well as the promotion of physical activity, healthy eating habits, and smoking cessation. UCAN has five work groups and eight committees that have created and are now working on the strategies from the 2016-2020 state cancer plan.
Health Program InformationIn 1976, the Utah Department of Health received a cervical cancer grant from the National Cancer Institute. In 1980, the Utah Department of Health began providing clinical breast exams and Pap tests on a sliding fee scale. In 1993, state funding was appropriated for mammography. That same year, the Utah Cancer Control Program (UCCP) first received a capacity building grant from the Centers for Disease Control and Prevention (CDC) to lay the groundwork for breast and cervical cancer screening in Utah. A five year comprehensive grant was awarded to the program in 1994 to continue breast and cervical cancer screening. In October 1999, this grant was renewed for an additional five years. The UCCP continues to receive funding from the CDC for breast and cervical cancer screenings. With this funding, the UCCP and partners, including local health departments, mammography facilities, pathology laboratories, and private providers, have worked together to ensure the appropriate and timely provision of clinical services.
The UCCP continues to receive funding from the CDC to implement comprehensive cancer control strategies that were identified by Utah Cancer Action Network statewide partnership.
Starting in 2014, the UCCP also received funding from the CDC to implement cancer genomics strategies focused on Hereditary Breast and Ovarian Cancer (associated with BRCA1/2 mutations) and Lynch Syndrome cancers, specifically colorectal and uterine.